Preoperative serum CEA level is predictive for patient outcome in case of non-small cell lung cancer, especially squamous cell carcinoma

Yokohama Medical Journal

Volumn 56, Issue 5-6, 2005, Pages 541-546

  Osawa, Hiroyuki ^a,b   Sakamoto, Kazuhiro ^a   Hayashi, Yasufumi ^a   Maehara, Takamitsu ^a   Hasuo, Kimiatsu ^a   Rino, Yasushi ^a   Takanashi, Yoshinori ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF OCCUPATIONAL SAFETY AND HEALTH   (Japan)

Author keywords

Non small cell lung cancer (NSCLC); Predictive marker; Serum CEA

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PROGNOSIS; SMOKING; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 33745662415     PISSN: 03727726     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mountain CF: Revision in the International System for staging Lung Cancer. Chest, 111: 1710-1717, 1997.
2. Gold P, Freedman SO: Demonstration of tumor-specific antigen in human colony carcinoma by immunological tolerance and absorption techniques. J Exp Med, 121: 439-462, 1965.
3. Suzuki K, Nagai K, Yoshida J, et al: Prognostic factor in clinical stage I non-small cell lung cancer. Ann Thorac Surg, 67: 927-932, 1999.
4. Icard P, Regnard JF, Essomba A, Panebianco V, Magdeleinat P, Levasseur P: Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer. Ann Thorac Surg, 58: 811-814, 1994.
5. Sawabata N, Ohta M, Takada S, et al: Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer. Ann Thorac Surg, 74: 174-179, 2002.
6. Yamashita J, Matsuo A, Saishoji T, Hayashi N, Ogawa M: Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: A prospective study. J Thorac Cardiovasc Surg, 124: 299-305, 2002.
7. nd, et al: Molecular staging of lung cancer: Real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer-Preliminary results of Cancer and Leukemia Group B Trial 9761. J Thorac Cardiovasc Surg, 123: 484-491, 2002.
8. Jeffrey BR, Dunitz J, Rubins HB, Maddaus MA, Niewoehner DE: Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer. J Thorac Cardiovasc Surg, 116: 412-416, 1998.
9. Kim JC, Roh SA, Kim HC, et al: Coexpression of carcinoembryonic antigen and E-cadherin in colorectal adenocarcinoma with liver metastasis. J Gastrointest Surg, 7: 931-938, 2003.
10. Vincent RG, Chu TM, Fergen TB, Ostrander M: Carcinoembryonic antigen in 228 patients with carcinoma of the lung. Cancer, 36: 2069-2076, 1975.
11. Ford CHJ, Stokes HJ, Newman CE: Carcinoembryonic antigen and prognosis after radical surgery for lung cancer: immunocytochemical localization and serum levels. Br J Cancer, 44: 145-153, 1981.
12. Diez M, Torres A, Maestro ML: Prediction of survival and recurrence by serum and cytosolic levels 1f CEA, CA125 and SCC antigen in resectable non-small cell lung cancer. Br J Cancer, 73: 1248-1254, 1996.
13. Graziano SL, Tatum AH, Newman NB: The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer. Cancer Res, 54: 2908-2913, 1994.
14. Teixeria CR, Tanaka S, Yoshihara M, Sumii K, Kajiyama G, Shimamoto F: Carcinoembryonic antigen staining patterns at the invasive tumor margin predict the malignant potential of colorectal carcinoma. Oncology, 51: 228-233, 1994.
15. Hamada Y, Yamamura M, Hioki K, Yamamoto M, Narura H, Watanabe K: Immunohistochemical study of carcinoembryonic antigen in patients with colorectal cancer. Cancer, 55: 136-141, 1985.
16. Sawabata N, Hirano H, Inoue M, et al: Immunohistochemical Analysis of Resected Clinical Stage I Pulmonary Adenocarcinomas With High Preoperative Levels of Serum Carcinoembryonic Antigen. Ann Thorac Surg, 76: 203-207, 2003.
17. Niklinski J, Furman M, Laudanski J, Kozlowski M: Prognostic value of pretreatment CEA, SCC-Ag, CA 19-9 levels in sera of patients with non-small cell lung cancer. Eur Cancer Prevent, 1: 401-406, 1992.
18. Kulpa J, Wojcik E, Reinfuss M, Kolodziejski L: Carcinoembryonic Antigen, Squamous Cell Carcinoma Antigen, CYFRA 21-1, and Neuro-specific Enolase in Squamous Cell Lung Cancer Patients. Clin Chem, 48: 1931-1937, 2002.
19. Buccheri G, Ferrigno D, Vola F: Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and other prognostic indicator in squamous cell lung cancer. Lung cancer, 10: 21-33, 1993.
20. Vielh P, Spano JP, Grenier J, Chevalie TL Soria JC: Molecular prognostic factors in resectable non-small cell lung cancer. Crit Rev Oncol Hematol, 53: 193-197, 2005.